Regnier SA - Search Results

1

NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settings.

Schattenberg JM, Balp MM, Reinhart B, Tietz A, Regnier SA, Capkun G, Ye Q, Loeffler J, Pedrosa MC, Docherty M. Schattenberg JM, et al. Among authors: regnier sa. Sci Rep. 2023 Apr 5;13(1):5573. doi: 10.1038/s41598-023-32551-2. Sci Rep. 2023. PMID: 37019931 Free PMC article.

2

Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis.

Docherty M, Regnier SA, Capkun G, Balp MM, Ye Q, Janssens N, Tietz A, Löffler J, Cai J, Pedrosa MC, Schattenberg JM. Docherty M, et al. Among authors: regnier sa. J Am Med Inform Assoc. 2021 Jun 12;28(6):1235-1241. doi: 10.1093/jamia/ocab003. J Am Med Inform Assoc. 2021. PMID: 33684933 Free PMC article.

3

Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA.

Lotery AJ, Regnier S. Lotery AJ, et al. Eye (Lond). 2015 Mar;29(3):380-7. doi: 10.1038/eye.2014.308. Epub 2015 Jan 9. Eye (Lond). 2015. PMID: 25572584 Free PMC article.

4

Is the St. George's Respiratory Questionnaire an Appropriate Measure of Symptom Severity and Activity Limitations for Clinical Trials in COPD? Analysis of Pooled Data from Five Randomized Clinical Trials.

Loubert A, Regnault A, Meunier J, Gutzwiller FS, Regnier SA. Loubert A, et al. Among authors: regnier sa. Int J Chron Obstruct Pulmon Dis. 2020 Sep 8;15:2103-2113. doi: 10.2147/COPD.S261919. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32982203 Free PMC article.

5

Efficacy of Treatments for Macular Oedema Secondary to Branch Retinal Vein Occlusion: A Network Meta-Analysis.

Regnier S, Bezlyak V. Regnier S, et al. Value Health. 2014 Nov;17(7):A604. doi: 10.1016/j.jval.2014.08.2099. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202090 Free article. No abstract available.

6

Response to 'Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the U.S.A.'.

Lotery A, Regnier S. Lotery A, et al. Eye (Lond). 2015 Aug;29(8):1113-4. doi: 10.1038/eye.2015.69. Epub 2015 May 15. Eye (Lond). 2015. PMID: 25976640 Free PMC article. No abstract available.

7

Potential impact of vaccination against Neisseria meningitidis on Neisseria gonorrhoeae in the United States: results from a decision-analysis model.

Régnier SA, Huels J. Régnier SA, et al. Hum Vaccin Immunother. 2014;10(12):3737-45. doi: 10.4161/hv.36221. Hum Vaccin Immunother. 2014. PMID: 25483706 Free PMC article.

8

Market watch: Forecasting market share in the US pharmaceutical market.

Regnier SA, Ridley DB. Regnier SA, et al. Nat Rev Drug Discov. 2015 Sep;14(9):594-5. doi: 10.1038/nrd4697. Epub 2015 Aug 14. Nat Rev Drug Discov. 2015. PMID: 26272192 No abstract available.

9

Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective.

Régnier SA, Malcolm W, Haig J, Xue W. Régnier SA, et al. Clinicoecon Outcomes Res. 2015 May 6;7:235-47. doi: 10.2147/CEOR.S82556. eCollection 2015. Clinicoecon Outcomes Res. 2015. PMID: 25999748 Free PMC article.

10

Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis.

Régnier S, Malcolm W, Allen F, Wright J, Bezlyak V. Régnier S, et al. PLoS One. 2014 Jul 16;9(7):e102309. doi: 10.1371/journal.pone.0102309. eCollection 2014. PLoS One. 2014. PMID: 25029255 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters